precision medicine

Krogan Q&A: Collaboration and the new era of science

Fri Jun 14, 2024

Nevan Krogan, PhD

In the Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG), Nevan Krogan, PhD, built a transdisciplinary, multi-lab, multi-institutional, multi-national, multi-sector open-science consortium in which over a thousand trainees and senior investigators worked together—overcoming...

Phillips explores policy, ethics, and precision medicine

Fri May 24, 2024

Kathryn A. Phillips, PhD

Department of Clinical Pharmacy faculty member Kathryn A. Phillips, PhD, is tackling the intersection of policy, ethics, and precision medicine in a series of collaborations with global impact.

Savic receives NIH funding to establish tuberculosis consortium

Mon Apr 1, 2024

Rada Savic, PhD

The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.

Emily Mrig, PhD

Tue Sep 13, 2022

David Schmidt

Assistant Professor

I am a member of the Center for Translational and Policy Research on Precision Medicine (TRANSPERS). I am interested in the ways that insurance coverage and health policy shape differential access and uptake of precision medicine. I am particularly interested in applying my research towards efforts...

School faculty members argue for the responsible use of genetic ancestry in health care

Wed Mar 10, 2021

Akinyemi Oni-Orisan, PharmD, PhD

Burchard and Oni-Orisan contribute to two opinion pieces grappling with issues of race and inequity in medicine

Genomes from over 50,000 people to help bring precision medicine to all

Mon Mar 8, 2021

Elisabeth Fall

Ryan Hernandez, PhD

Collaborative effort ensures precision medicine will be based on the genetics of a diverse pool of people

Jeroen Jansen, PhD

Wed May 6, 2020

Associate Professor

I am a member of the Center for Translational and Policy Research on Precision Medicine (TRANSPERS). I work on applied and methods research to understand the clinical and economic value of drugs and other health technologies.

Asthma drug response in racially diverse children

Wed Mar 7, 2018

Sam S. Oh

Senior Author Esteban G. Burchard, MD, MPH

“Whole genome sequencing of pharmacogenetic drug response in racially diverse children with asthma” has been published by the American Journal of Respiratory and Critical Care Medicine (ARJCCM).

Burchard leads call for diversity in research workforce

Thu Jun 16, 2016

Noah Berger

Marquitta White (right), MS, PhD, a postdoctoral fellow in the Burchard Lab, took on five young summer research students of diverse backgrounds, including Maria Contreras (left) and Oona Risse-Adams (center), a 16-year-old sophomore at Lowell High School in San Francisco.

The photograph of Martin Luther King Jr. hanging on the wall of the Asthma Collaboratory lab in UC San Francisco’s Rock Hall serves a reminder to all who toil there, purifying DNA samples or analyzing genetic, social or environmental data that their research is also part of a dream of equality and...

Classroom pharmacogenetics, post-hospital medications, and post-brain-surgery drugs take top honors

Thu May 26, 2016